To summarise, the present study further supports that LPS-activated inflammasomes accelerate neuroinflammation and lead to depression by triggering PPARγ/CX3CR1/Nrf2 and the NF-κB/NLRP3 signaling pathways. Here, NFE2L2 is linked to depressive disorder.